Lv1
40 积分 2024-06-03 加入
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma
3天前
已完结
Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis
3天前
已完结
Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors
3天前
已完结
皖公网安备34019202002308
